Skip to content

Clinical trials

Phase 1 Lupus Erythematosus, Systemic trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 1 Country / region: Poland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20151
20182
20191
20201
20221
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Bristol-Myers Squibb2
GlaxoSmithKline2
Hoffmann-La Roche2
Biocon Limited1
IGM Biosciences, Inc.1
Janssen Research & Development, LLC1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Lakefront Biotherapeutics NV1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic15
Arthritis, Rheumatoid3
Autoimmune Diseases3
Connective Tissue Diseases3
Dermatomyositis3
Lupus Nephritis3
Myositis3
Scleroderma, Systemic3
Sjogren's Syndrome3
Lung Diseases, Interstitial2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.